During the past decade, University Clinic Golnik conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Clinic Golnik" #1 sponsor was "The University Clinic of Pulmonary and Allergic Diseases Golnik" with 10 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Aleš Rozman" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinic Golnik" #1 collaborator was "The University Clinic of Pulmonary and Allergic Diseases Golnik" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "University Clinic Golnik" are "Pleural Diseases" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Chronic Heart Failure" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "University Clinic Golnik" in a lesser frequency.

Most popular intervention types in "University Clinic Golnik" are "Drug" (13 trials), "Device" (4 trials), "Other" (4 trials), "Genetic" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Advice on DDIs" (1 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "BM32" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Clinic Golnik" are 30 trials for "All" genders.

Currently, there are NaN active trials in "University Clinic Golnik". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in University Clinic Golnik, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Clinic Golnik, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".